Company Executive Sells 30,000 Shares of $GPK

Recently, Joseph P. Yost, the Executive Vice President and President of $GPK, made a significant sale of 30,000 shares of the company on 08-25-2025, totaling an estimated $681,600. This transaction represented approximately 10.5% of their holdings in this class of stock, leaving them with 255,203 shares of $GPK stock. Data on this trade was obtained from a recent filing with the Securities and Exchange Commission (SEC).

In the past six months, $GPK insiders have engaged in three trades involving the company’s stock on the open market. Out of these transactions, there have been no acquisitions and three sales. One notable insider, Philip R. Martens, has conducted two sales, divesting 63,752 shares for an estimated amount of $1,392,063. Additionally, Joseph P. Yost, the EVP & President of the Americas, sold 30,000 shares for $681,600.

Regarding institutional investor activity, there has been notable movement in the $GPK stock portfolio. A total of 215 institutional investors have increased their holdings, while 330 have opted to decrease their positions in the most recent quarter. Among some of the significant changes, UBS Group AG removed a substantial 4,781,411 shares (a decrease of 70.8%) from their portfolio, amounting to an estimated $100,744,329. Conversely, DME Capital Management, LP added 3,658,850 shares (a significant increase of 349.4%) in Q2 2025, totaling an estimated $77,091,969.

In congressional stock trading activities related to $GPK, there has been a single instance of trading in the past six months. This transaction involved a purchase by Representative Lisa C. McClain, who acquired up to $15,000 worth of $GPK stock on 06/17.

It is worth noting that various Wall Street analysts have issued reports on $GPK in recent months. Among these reports, three firms have issued buy ratings on the stock, while none have issued sell ratings. Notable analyst ratings include B of A Securities issuing a “Buy” rating on 07/09/2025, RBC Capital issuing an “Outperform” rating on 06/18/2025, and Raymond James issuing an “Outperform” rating on 05/02/2025.

Several analysts have also provided price targets for $GPK in the last six months. A total of six analysts have offered price targets, with a median target of $24.5. Some noteworthy targets include Gabe Hajde from Wells Fargo setting a target price of $23.0 on 07/18/2025, Michael Roxland from Truist Securities setting a target price of $23.0 on 07/11/2025, and George Staphos from B of A Securities setting a target price of $28.0 on 07/09/2025.

In conclusion, the recent insider sale and subsequent activities surrounding $GPK stock reflect significant movements in the company’s financial landscape, impacting both insiders and institutional investors alike. Investors and analysts closely monitor these transactions and ratings to assess the market sentiment surrounding $GPK.